Stan Berenshteyn
Stock Analyst at Wells Fargo
(2.15)
# 2,905
Out of 5,005 analysts
67
Total ratings
52.63%
Success rate
-8.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $326 → $341 | $296.28 | +15.09% | 8 | Aug 28, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $6 | $2.96 | +102.70% | 6 | Aug 11, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $73.26 | -11.27% | 12 | Aug 8, 2025 | |
| AMWL American Well | Maintains: Overweight | $15 → $12 | $6.33 | +89.57% | 4 | Aug 7, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $30.95 | +29.24% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $9.01 | -11.21% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $4.53 | +54.53% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $88.59 | +41.10% | 9 | Feb 26, 2025 |
Veeva Systems
Aug 28, 2025
Maintains: Overweight
Price Target: $326 → $341
Current: $296.28
Upside: +15.09%
Health Catalyst
Aug 11, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $2.96
Upside: +102.70%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $73.26
Upside: -11.27%
American Well
Aug 7, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $6.33
Upside: +89.57%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $30.95
Upside: +29.24%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $9.01
Upside: -11.21%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $4.53
Upside: +54.53%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $88.59
Upside: +41.10%